This activity is expired and is no longer available for CME credit.


A Phase 2a Study of Darapladib, an Oral Lipoprotein-associated Phospholipase A2 Inhibitor, in Diabetic Macular Edema

Author(s)/Faculty: Giovanni Staurenghi, MD
Release Date: 12/16/2013Expiration Date: 12/15/2014
Credit Type: CMENumber of Credits: 0
Content Type: MultimediaProvider:
I’m here at AAO to present on behalf of an entire group that participate to a multicenter phase 2 study of darapladib...